Name |
Number of Publications
|
Most Recent Publication
|
Publications by All Authors
|
Concept Score
|
Why?
|
---|
Selenoproteins | 53 | 2022 | 151 | 9.100 |
Why?
|
Selenium | 41 | 2022 | 144 | 7.300 |
Why?
|
Selenocysteine | 36 | 2014 | 52 | 5.220 |
Why?
|
Selenoprotein P | 20 | 2022 | 50 | 4.470 |
Why?
|
Lyases | 10 | 2021 | 51 | 4.320 |
Why?
|
Iodide Peroxidase | 27 | 2021 | 32 | 2.810 |
Why?
|
Protein Biosynthesis | 22 | 2007 | 123 | 2.290 |
Why?
|
Proteins | 17 | 2003 | 352 | 2.150 |
Why?
|
RNA, Messenger | 27 | 2017 | 1152 | 2.050 |
Why?
|
Schools, Medical | 5 | 2018 | 192 | 1.830 |
Why?
|
Animals | 89 | 2022 | 14307 | 1.750 |
Why?
|
Leptin | 5 | 2021 | 115 | 1.740 |
Why?
|
RNA-Binding Proteins | 14 | 2009 | 145 | 1.700 |
Why?
|
Energy Metabolism | 7 | 2021 | 160 | 1.690 |
Why?
|
RNA, Transfer, Amino Acid-Specific | 6 | 2021 | 14 | 1.590 |
Why?
|
Obesity | 8 | 2021 | 965 | 1.440 |
Why?
|
Codon | 13 | 2006 | 38 | 1.430 |
Why?
|
Hypothalamus | 4 | 2019 | 122 | 1.410 |
Why?
|
Molecular Biology | 3 | 2015 | 44 | 1.370 |
Why?
|
Brain | 9 | 2017 | 1268 | 1.330 |
Why?
|
Sex Characteristics | 3 | 2021 | 213 | 1.180 |
Why?
|
Mice, Knockout | 15 | 2021 | 897 | 1.170 |
Why?
|
Cell Line | 27 | 2014 | 1289 | 1.140 |
Why?
|
Oxidative Stress | 16 | 2021 | 874 | 1.120 |
Why?
|
Mice | 34 | 2021 | 5668 | 1.120 |
Why?
|
Neurons | 5 | 2022 | 1130 | 1.050 |
Why?
|
Glutathione Peroxidase | 13 | 2022 | 109 | 0.980 |
Why?
|
Nerve Tissue Proteins | 3 | 2015 | 338 | 0.910 |
Why?
|
Humans | 75 | 2023 | 34853 | 0.910 |
Why?
|
Cell Biology | 2 | 2014 | 11 | 0.890 |
Why?
|
Mice, Inbred C57BL | 13 | 2021 | 1530 | 0.870 |
Why?
|
Body Weight | 4 | 2021 | 404 | 0.850 |
Why?
|
Eukaryotic Cells | 7 | 2008 | 32 | 0.850 |
Why?
|
Codon, Terminator | 8 | 2013 | 12 | 0.830 |
Why?
|
Endocrinology | 1 | 2021 | 2 | 0.810 |
Why?
|
Adipocytes, Brown | 1 | 2021 | 8 | 0.790 |
Why?
|
Thermogenesis | 1 | 2021 | 20 | 0.790 |
Why?
|
RNA, Transfer, Amino Acyl | 9 | 2013 | 9 | 0.750 |
Why?
|
Seafood | 3 | 2015 | 19 | 0.730 |
Why?
|
Universities | 2 | 2015 | 363 | 0.730 |
Why?
|
Peptide Elongation Factors | 7 | 2008 | 11 | 0.720 |
Why?
|
Agouti-Related Protein | 1 | 2019 | 11 | 0.710 |
Why?
|
Gene Deletion | 4 | 2021 | 156 | 0.710 |
Why?
|
Glutathione | 5 | 2007 | 160 | 0.700 |
Why?
|
3' Untranslated Regions | 3 | 2008 | 67 | 0.690 |
Why?
|
Mercury | 2 | 2015 | 35 | 0.640 |
Why?
|
Fetal Blood | 2 | 2015 | 47 | 0.630 |
Why?
|
Thyroid Hormones | 5 | 2005 | 26 | 0.630 |
Why?
|
Molecular Sequence Data | 23 | 2014 | 1490 | 0.610 |
Why?
|
Adipose Tissue, Brown | 4 | 2021 | 39 | 0.590 |
Why?
|
Transfection | 18 | 2017 | 496 | 0.590 |
Why?
|
Male | 26 | 2023 | 18870 | 0.570 |
Why?
|
Amino Acid Sequence | 20 | 2014 | 1124 | 0.570 |
Why?
|
Liver | 11 | 2021 | 447 | 0.570 |
Why?
|
Research | 2 | 2015 | 159 | 0.560 |
Why?
|
Curriculum | 1 | 2018 | 237 | 0.550 |
Why?
|
Cysteine | 8 | 2003 | 88 | 0.550 |
Why?
|
DNA-Binding Proteins | 3 | 2009 | 522 | 0.530 |
Why?
|
Behavior, Animal | 2 | 2014 | 304 | 0.520 |
Why?
|
Phosphotransferases | 7 | 2014 | 35 | 0.510 |
Why?
|
Bambusa | 3 | 2010 | 10 | 0.510 |
Why?
|
Gene Expression Regulation | 8 | 2017 | 968 | 0.510 |
Why?
|
Neurodegenerative Diseases | 2 | 2014 | 119 | 0.510 |
Why?
|
Education, Graduate | 2 | 2014 | 27 | 0.500 |
Why?
|
Up-Regulation | 4 | 2015 | 490 | 0.500 |
Why?
|
Female | 22 | 2023 | 19873 | 0.500 |
Why?
|
Nucleic Acid Conformation | 7 | 2006 | 142 | 0.500 |
Why?
|
Biomedical Research | 4 | 2023 | 371 | 0.480 |
Why?
|
Seizures | 1 | 2014 | 67 | 0.480 |
Why?
|
Blotting, Western | 9 | 2015 | 834 | 0.460 |
Why?
|
Hawaii | 8 | 2023 | 1878 | 0.460 |
Why?
|
Palmitic Acid | 2 | 2015 | 24 | 0.460 |
Why?
|
Genome, Human | 1 | 2013 | 112 | 0.430 |
Why?
|
Mammals | 4 | 2009 | 96 | 0.430 |
Why?
|
Putamen | 1 | 2012 | 15 | 0.420 |
Why?
|
Base Sequence | 15 | 2007 | 932 | 0.420 |
Why?
|
Substantia Nigra | 1 | 2012 | 41 | 0.420 |
Why?
|
Plant Extracts | 3 | 2011 | 250 | 0.420 |
Why?
|
Transcription, Genetic | 5 | 2009 | 550 | 0.410 |
Why?
|
Antioxidants | 5 | 2013 | 386 | 0.410 |
Why?
|
Cloning, Molecular | 6 | 2021 | 310 | 0.380 |
Why?
|
DNA Transposable Elements | 2 | 2002 | 44 | 0.380 |
Why?
|
Superoxides | 2 | 2007 | 51 | 0.380 |
Why?
|
Glutathione Transferase | 3 | 2010 | 83 | 0.380 |
Why?
|
Parkinson Disease | 1 | 2012 | 167 | 0.370 |
Why?
|
Cytosol | 1 | 2010 | 85 | 0.370 |
Why?
|
Dietary Supplements | 4 | 2016 | 196 | 0.370 |
Why?
|
Cognition | 1 | 2013 | 373 | 0.370 |
Why?
|
Disease | 1 | 2009 | 18 | 0.360 |
Why?
|
Flow Cytometry | 2 | 2008 | 392 | 0.350 |
Why?
|
Ribosomes | 2 | 2006 | 27 | 0.350 |
Why?
|
Transcription Factors | 2 | 2015 | 653 | 0.350 |
Why?
|
Methylmercury Compounds | 1 | 2009 | 3 | 0.350 |
Why?
|
Mercury Poisoning | 1 | 2009 | 5 | 0.350 |
Why?
|
Ribosomal Proteins | 2 | 2008 | 19 | 0.350 |
Why?
|
Gene Expression | 11 | 2012 | 639 | 0.350 |
Why?
|
Alzheimer Disease | 3 | 2015 | 881 | 0.340 |
Why?
|
Immunity | 1 | 2008 | 51 | 0.330 |
Why?
|
Drosophila Proteins | 2 | 2003 | 162 | 0.330 |
Why?
|
Zebrafish Proteins | 2 | 2006 | 45 | 0.330 |
Why?
|
Methamphetamine | 3 | 2015 | 155 | 0.320 |
Why?
|
Membrane Proteins | 3 | 2017 | 486 | 0.320 |
Why?
|
Proteome | 2 | 2007 | 132 | 0.320 |
Why?
|
Cell Nucleus | 3 | 2006 | 351 | 0.320 |
Why?
|
Databases, Protein | 1 | 2008 | 47 | 0.320 |
Why?
|
Lung | 2 | 2007 | 413 | 0.320 |
Why?
|
Mutagenesis, Site-Directed | 7 | 2003 | 168 | 0.320 |
Why?
|
RNA Stability | 1 | 2007 | 24 | 0.310 |
Why?
|
Lymphocyte Subsets | 1 | 2007 | 19 | 0.310 |
Why?
|
Respiratory Hypersensitivity | 1 | 2007 | 15 | 0.310 |
Why?
|
Weight Gain | 2 | 2019 | 128 | 0.310 |
Why?
|
Metabolic Detoxication, Phase II | 1 | 2007 | 4 | 0.310 |
Why?
|
Electron Transport Chain Complex Proteins | 1 | 2007 | 12 | 0.310 |
Why?
|
Apoferritins | 1 | 2007 | 5 | 0.310 |
Why?
|
Hippocampus | 3 | 2007 | 546 | 0.310 |
Why?
|
Neuroprotective Agents | 1 | 2010 | 231 | 0.310 |
Why?
|
Adiposity | 2 | 2019 | 145 | 0.300 |
Why?
|
Minority Groups | 3 | 2023 | 537 | 0.300 |
Why?
|
Calcium | 1 | 2010 | 445 | 0.300 |
Why?
|
Rats | 20 | 2013 | 3261 | 0.300 |
Why?
|
Signal Transduction | 3 | 2021 | 1802 | 0.300 |
Why?
|
RNA, Transfer | 7 | 2008 | 26 | 0.300 |
Why?
|
Asthma | 2 | 2008 | 363 | 0.290 |
Why?
|
Cerebral Cortex | 1 | 2008 | 274 | 0.290 |
Why?
|
Chemoprevention | 1 | 2006 | 34 | 0.290 |
Why?
|
Diet | 5 | 2016 | 747 | 0.290 |
Why?
|
Pre-Eclampsia | 2 | 2019 | 57 | 0.290 |
Why?
|
Gene Expression Regulation, Enzymologic | 1 | 2007 | 160 | 0.290 |
Why?
|
Tetraodontiformes | 1 | 2005 | 3 | 0.280 |
Why?
|
Fish Proteins | 1 | 2005 | 11 | 0.280 |
Why?
|
Cells, Cultured | 4 | 2021 | 1442 | 0.280 |
Why?
|
Multiprotein Complexes | 1 | 2006 | 53 | 0.270 |
Why?
|
Thioredoxin-Disulfide Reductase | 2 | 2009 | 5 | 0.270 |
Why?
|
Glucose Intolerance | 2 | 2018 | 42 | 0.270 |
Why?
|
Mutation, Missense | 1 | 2005 | 80 | 0.270 |
Why?
|
Buthionine Sulfoximine | 1 | 2005 | 10 | 0.270 |
Why?
|
Blood Glucose | 2 | 2018 | 333 | 0.260 |
Why?
|
Reverse Transcriptase Polymerase Chain Reaction | 4 | 2009 | 605 | 0.260 |
Why?
|
Protein Structure, Tertiary | 4 | 2014 | 383 | 0.240 |
Why?
|
Mutation | 7 | 2017 | 1023 | 0.240 |
Why?
|
Mitochondria | 1 | 2007 | 454 | 0.240 |
Why?
|
Age Factors | 2 | 2018 | 1007 | 0.240 |
Why?
|
Regulatory Sequences, Nucleic Acid | 2 | 2000 | 45 | 0.230 |
Why?
|
Brain Diseases | 1 | 2003 | 33 | 0.230 |
Why?
|
Gene Knockdown Techniques | 3 | 2014 | 161 | 0.230 |
Why?
|
Recombinant Proteins | 6 | 2008 | 485 | 0.220 |
Why?
|
Sequence Alignment | 5 | 2014 | 257 | 0.220 |
Why?
|
Sequence Homology, Amino Acid | 8 | 2006 | 249 | 0.220 |
Why?
|
Genes | 3 | 2019 | 58 | 0.220 |
Why?
|
Organoselenium Compounds | 2 | 2020 | 9 | 0.220 |
Why?
|
Amnion | 2 | 2014 | 17 | 0.220 |
Why?
|
Sequence Analysis, DNA | 2 | 2021 | 455 | 0.220 |
Why?
|
Disease Models, Animal | 4 | 2021 | 1300 | 0.220 |
Why?
|
Drosophila melanogaster | 1 | 2003 | 168 | 0.210 |
Why?
|
History, 21st Century | 2 | 2021 | 74 | 0.210 |
Why?
|
History, 20th Century | 2 | 2021 | 110 | 0.210 |
Why?
|
Education, Medical | 2 | 2018 | 97 | 0.210 |
Why?
|
Peptide Chain Termination, Translational | 1 | 2001 | 1 | 0.210 |
Why?
|
Peptide Termination Factors | 1 | 2001 | 3 | 0.210 |
Why?
|
Glucose Tolerance Test | 1 | 2021 | 66 | 0.210 |
Why?
|
Cell Line, Tumor | 5 | 2017 | 2128 | 0.200 |
Why?
|
Protein Binding | 6 | 2007 | 913 | 0.200 |
Why?
|
Polyribosomes | 1 | 2001 | 3 | 0.200 |
Why?
|
Carbon Dioxide | 1 | 2021 | 78 | 0.200 |
Why?
|
Simvastatin | 1 | 2021 | 28 | 0.200 |
Why?
|
Amino Acids | 2 | 2019 | 139 | 0.200 |
Why?
|
Biosynthetic Pathways | 1 | 2021 | 13 | 0.200 |
Why?
|
RNA Precursors | 2 | 2014 | 25 | 0.200 |
Why?
|
Binding Sites | 5 | 2007 | 597 | 0.190 |
Why?
|
RNA | 2 | 2005 | 234 | 0.190 |
Why?
|
Azoles | 1 | 2020 | 13 | 0.190 |
Why?
|
Oxidation-Reduction | 3 | 2018 | 407 | 0.190 |
Why?
|
Genes, Reporter | 3 | 2009 | 132 | 0.190 |
Why?
|
Promoter Regions, Genetic | 3 | 2014 | 484 | 0.190 |
Why?
|
Genes, Helminth | 1 | 1999 | 7 | 0.180 |
Why?
|
Metabolome | 1 | 2019 | 47 | 0.180 |
Why?
|
Gene Knockout Techniques | 1 | 2019 | 46 | 0.180 |
Why?
|
Nutritional Status | 2 | 2020 | 114 | 0.180 |
Why?
|
Kidney | 6 | 2009 | 322 | 0.170 |
Why?
|
Muscle, Skeletal | 1 | 2021 | 257 | 0.170 |
Why?
|
Coronavirus Infections | 1 | 2020 | 63 | 0.170 |
Why?
|
Pneumonia, Viral | 1 | 2020 | 70 | 0.170 |
Why?
|
Caenorhabditis elegans | 1 | 1999 | 74 | 0.170 |
Why?
|
Behavioral Research | 1 | 2019 | 37 | 0.170 |
Why?
|
DNA Primers | 3 | 2009 | 269 | 0.170 |
Why?
|
Aged, 80 and over | 4 | 2017 | 2333 | 0.170 |
Why?
|
Proto-Oncogene Proteins c-akt | 2 | 2012 | 245 | 0.170 |
Why?
|
Cell Survival | 3 | 2008 | 818 | 0.170 |
Why?
|
Minority Health | 1 | 2019 | 81 | 0.170 |
Why?
|
Selenium Radioisotopes | 4 | 2002 | 4 | 0.160 |
Why?
|
Pregnancy | 4 | 2019 | 1503 | 0.160 |
Why?
|
Orchiectomy | 1 | 2018 | 33 | 0.160 |
Why?
|
Genetic Predisposition to Disease | 2 | 2019 | 528 | 0.160 |
Why?
|
Histidine | 2 | 2000 | 36 | 0.160 |
Why?
|
Ovalbumin | 2 | 2007 | 43 | 0.160 |
Why?
|
Models, Biological | 5 | 2007 | 642 | 0.150 |
Why?
|
Time Factors | 3 | 2018 | 1681 | 0.150 |
Why?
|
Cytoplasm | 3 | 2006 | 135 | 0.150 |
Why?
|
Placenta | 2 | 2015 | 91 | 0.150 |
Why?
|
CD4-Positive T-Lymphocytes | 2 | 2010 | 251 | 0.150 |
Why?
|
Phosphoproteins | 2 | 2008 | 154 | 0.150 |
Why?
|
Aging | 3 | 2015 | 639 | 0.150 |
Why?
|
Protein Isoforms | 2 | 2014 | 121 | 0.150 |
Why?
|
Neoplasms | 1 | 2006 | 1033 | 0.140 |
Why?
|
Isoenzymes | 2 | 1997 | 149 | 0.140 |
Why?
|
Faculty, Medical | 2 | 2014 | 63 | 0.140 |
Why?
|
Diabetes Mellitus, Type 2 | 2 | 2016 | 592 | 0.140 |
Why?
|
Epilepsy, Reflex | 1 | 2015 | 5 | 0.140 |
Why?
|
Castration | 1 | 2015 | 33 | 0.140 |
Why?
|
Insulin | 1 | 2018 | 224 | 0.140 |
Why?
|
Glutamate Decarboxylase | 1 | 2015 | 17 | 0.140 |
Why?
|
Food, Fortified | 1 | 2016 | 17 | 0.140 |
Why?
|
Dizocilpine Maleate | 1 | 2015 | 45 | 0.140 |
Why?
|
Thyroid Gland | 2 | 1995 | 17 | 0.140 |
Why?
|
Polymorphism, Single Nucleotide | 1 | 2019 | 638 | 0.140 |
Why?
|
tau Proteins | 1 | 2017 | 161 | 0.140 |
Why?
|
RNA, Transfer, Ser | 2 | 2006 | 3 | 0.140 |
Why?
|
Genotype | 1 | 2018 | 641 | 0.140 |
Why?
|
Maze Learning | 1 | 2015 | 100 | 0.130 |
Why?
|
Exploratory Behavior | 1 | 2015 | 72 | 0.130 |
Why?
|
Autoantigens | 2 | 2006 | 82 | 0.130 |
Why?
|
Heat-Shock Proteins | 1 | 2015 | 51 | 0.130 |
Why?
|
Calcium Channels, L-Type | 1 | 2015 | 19 | 0.130 |
Why?
|
Iodine | 2 | 1997 | 6 | 0.130 |
Why?
|
Phenotype | 1 | 2018 | 650 | 0.130 |
Why?
|
Animal Nutritional Physiological Phenomena | 1 | 1995 | 9 | 0.130 |
Why?
|
Choroid Plexus | 1 | 2015 | 6 | 0.130 |
Why?
|
Calcium Channel Blockers | 1 | 2015 | 56 | 0.130 |
Why?
|
Anticodon | 1 | 1994 | 1 | 0.130 |
Why?
|
DNA | 6 | 2014 | 549 | 0.130 |
Why?
|
Fishes | 1 | 2015 | 48 | 0.130 |
Why?
|
Substrate Specificity | 2 | 2014 | 186 | 0.130 |
Why?
|
Chorion | 1 | 2014 | 8 | 0.130 |
Why?
|
Analysis of Variance | 2 | 2017 | 528 | 0.130 |
Why?
|
Organogenesis | 1 | 2014 | 16 | 0.130 |
Why?
|
RNA Helicases | 1 | 2014 | 16 | 0.130 |
Why?
|
RNA Processing, Post-Transcriptional | 1 | 2014 | 26 | 0.130 |
Why?
|
HIV Infections | 3 | 2015 | 2207 | 0.120 |
Why?
|
Archaea | 2 | 2007 | 14 | 0.120 |
Why?
|
Amphetamine-Related Disorders | 1 | 2015 | 63 | 0.120 |
Why?
|
Point Mutation | 3 | 2003 | 88 | 0.120 |
Why?
|
Acquired Immunodeficiency Syndrome | 2 | 2008 | 214 | 0.120 |
Why?
|
Phosphorylation | 4 | 2017 | 878 | 0.120 |
Why?
|
Nervous System Diseases | 1 | 2014 | 66 | 0.120 |
Why?
|
Education, Medical, Undergraduate | 1 | 2014 | 75 | 0.120 |
Why?
|
Mice, Transgenic | 1 | 2015 | 608 | 0.120 |
Why?
|
DNA Mutational Analysis | 4 | 2003 | 89 | 0.120 |
Why?
|
Mice, Inbred Strains | 1 | 1993 | 117 | 0.120 |
Why?
|
Inflammation | 2 | 2008 | 577 | 0.120 |
Why?
|
Income | 1 | 2014 | 135 | 0.120 |
Why?
|
Trans-Activators | 1 | 2014 | 167 | 0.120 |
Why?
|
Endocytosis | 1 | 2014 | 104 | 0.120 |
Why?
|
Cardiovascular Diseases | 1 | 2019 | 628 | 0.110 |
Why?
|
Motor Activity | 1 | 2015 | 393 | 0.110 |
Why?
|
Protein Tyrosine Phosphatase, Non-Receptor Type 1 | 1 | 2012 | 7 | 0.110 |
Why?
|
Locomotion | 1 | 2013 | 91 | 0.110 |
Why?
|
Ligands | 1 | 2014 | 317 | 0.110 |
Why?
|
Zebrafish | 2 | 2006 | 118 | 0.110 |
Why?
|
Hyperinsulinism | 1 | 2012 | 17 | 0.110 |
Why?
|
RNA, Untranslated | 1 | 2012 | 42 | 0.110 |
Why?
|
Bacterial Proteins | 2 | 2007 | 520 | 0.110 |
Why?
|
Alternative Splicing | 1 | 2012 | 82 | 0.110 |
Why?
|
Hypercholesterolemia | 1 | 2012 | 36 | 0.110 |
Why?
|
Sex Factors | 1 | 2015 | 859 | 0.110 |
Why?
|
AMP-Activated Protein Kinases | 1 | 2012 | 49 | 0.110 |
Why?
|
Epigenesis, Genetic | 1 | 2014 | 198 | 0.110 |
Why?
|
Stereotaxic Techniques | 1 | 2012 | 20 | 0.110 |
Why?
|
Precipitin Tests | 2 | 2003 | 51 | 0.100 |
Why?
|
Fatty Liver | 1 | 2012 | 56 | 0.100 |
Why?
|
Tyrosine 3-Monooxygenase | 1 | 2012 | 72 | 0.100 |
Why?
|
alpha-Synuclein | 1 | 2012 | 48 | 0.100 |
Why?
|
Sequence Analysis, RNA | 2 | 2012 | 104 | 0.100 |
Why?
|
Poaceae | 1 | 2011 | 11 | 0.100 |
Why?
|
DNA Methylation | 1 | 2014 | 301 | 0.100 |
Why?
|
Dogs | 5 | 1999 | 138 | 0.100 |
Why?
|
Oligonucleotide Array Sequence Analysis | 2 | 2014 | 298 | 0.100 |
Why?
|
Open Reading Frames | 2 | 2001 | 73 | 0.100 |
Why?
|
Microscopy, Confocal | 2 | 2008 | 210 | 0.100 |
Why?
|
RNA Interference | 3 | 2012 | 225 | 0.100 |
Why?
|
Drugs, Chinese Herbal | 1 | 2010 | 20 | 0.100 |
Why?
|
Reactive Oxygen Species | 2 | 2010 | 416 | 0.090 |
Why?
|
Glycosylation | 2 | 2000 | 92 | 0.090 |
Why?
|
Chemokine CCL2 | 1 | 2011 | 82 | 0.090 |
Why?
|
Feeding Behavior | 1 | 2014 | 418 | 0.090 |
Why?
|
Oxidants | 1 | 2010 | 43 | 0.090 |
Why?
|
Gene Silencing | 2 | 2008 | 143 | 0.090 |
Why?
|
Kinetics | 5 | 1997 | 650 | 0.090 |
Why?
|
Sulfhydryl Compounds | 1 | 2010 | 46 | 0.090 |
Why?
|
Macaca | 1 | 2009 | 38 | 0.090 |
Why?
|
Aged | 3 | 2017 | 6448 | 0.090 |
Why?
|
Luminescent Proteins | 1 | 2010 | 74 | 0.090 |
Why?
|
Luciferases | 1 | 2009 | 62 | 0.090 |
Why?
|
Calcium-Binding Proteins | 1 | 2010 | 72 | 0.090 |
Why?
|
RNA, Small Interfering | 4 | 2017 | 391 | 0.090 |
Why?
|
Triiodothyronine | 3 | 1995 | 30 | 0.090 |
Why?
|
Genomics | 2 | 2008 | 201 | 0.090 |
Why?
|
Lymphocyte Activation | 1 | 2010 | 222 | 0.090 |
Why?
|
Hydrogen Peroxide | 1 | 2010 | 181 | 0.090 |
Why?
|
Telomerase | 1 | 2009 | 40 | 0.090 |
Why?
|
Recombinant Fusion Proteins | 3 | 2007 | 286 | 0.090 |
Why?
|
Metals, Heavy | 1 | 2009 | 56 | 0.090 |
Why?
|
Telomere | 1 | 2009 | 51 | 0.090 |
Why?
|
Neocortex | 1 | 2008 | 26 | 0.090 |
Why?
|
Research Personnel | 2 | 2021 | 133 | 0.080 |
Why?
|
Cross-Linking Reagents | 1 | 2008 | 48 | 0.080 |
Why?
|
9,10-Dimethyl-1,2-benzanthracene | 1 | 2008 | 28 | 0.080 |
Why?
|
Protein Conformation | 2 | 2003 | 350 | 0.080 |
Why?
|
Cell Count | 1 | 2008 | 129 | 0.080 |
Why?
|
Depression | 1 | 2015 | 664 | 0.080 |
Why?
|
Neurofibrillary Tangles | 1 | 2008 | 112 | 0.080 |
Why?
|
Fatty Acids, Nonesterified | 1 | 2008 | 39 | 0.080 |
Why?
|
Phytotherapy | 1 | 2008 | 62 | 0.080 |
Why?
|
Astrocytes | 1 | 2010 | 203 | 0.080 |
Why?
|
Tissue Distribution | 2 | 2007 | 197 | 0.080 |
Why?
|
Vero Cells | 1 | 2008 | 90 | 0.080 |
Why?
|
Mammary Neoplasms, Experimental | 1 | 2008 | 70 | 0.080 |
Why?
|
Prokaryotic Cells | 2 | 1999 | 8 | 0.080 |
Why?
|
Diabetic Nephropathies | 1 | 2008 | 53 | 0.080 |
Why?
|
Interleukin-2 Receptor alpha Subunit | 1 | 2007 | 18 | 0.080 |
Why?
|
Sequence Analysis, Protein | 1 | 2008 | 49 | 0.080 |
Why?
|
STAT6 Transcription Factor | 1 | 2007 | 16 | 0.080 |
Why?
|
Malonates | 1 | 2007 | 2 | 0.080 |
Why?
|
User-Computer Interface | 1 | 2008 | 62 | 0.080 |
Why?
|
Polyenes | 1 | 2007 | 4 | 0.080 |
Why?
|
Antimycin A | 1 | 2007 | 5 | 0.080 |
Why?
|
Electron Transport Complex II | 1 | 2007 | 7 | 0.080 |
Why?
|
Bronchoalveolar Lavage Fluid | 1 | 2007 | 48 | 0.080 |
Why?
|
Electron Transport Complex III | 1 | 2007 | 12 | 0.080 |
Why?
|
High Mobility Group Proteins | 1 | 2007 | 4 | 0.080 |
Why?
|
Rotenone | 1 | 2007 | 18 | 0.080 |
Why?
|
Th2 Cells | 1 | 2007 | 56 | 0.080 |
Why?
|
Plasmids | 2 | 2003 | 233 | 0.080 |
Why?
|
Electron Transport Complex I | 1 | 2007 | 20 | 0.080 |
Why?
|
Immunoglobulin E | 1 | 2007 | 54 | 0.080 |
Why?
|
Homocysteine | 1 | 2007 | 18 | 0.080 |
Why?
|
HIV-1 | 1 | 2013 | 678 | 0.080 |
Why?
|
Diabetes Mellitus, Experimental | 1 | 2008 | 87 | 0.080 |
Why?
|
Allergens | 1 | 2007 | 58 | 0.080 |
Why?
|
Rats, Inbred Strains | 3 | 1991 | 132 | 0.080 |
Why?
|
Mice, Obese | 2 | 2021 | 37 | 0.070 |
Why?
|
Leishmania | 1 | 2006 | 17 | 0.070 |
Why?
|
Conserved Sequence | 3 | 1997 | 106 | 0.070 |
Why?
|
DNA Damage | 1 | 2009 | 341 | 0.070 |
Why?
|
Environmental Pollutants | 1 | 2009 | 166 | 0.070 |
Why?
|
Ultraviolet Rays | 1 | 2007 | 116 | 0.070 |
Why?
|
Sequence Deletion | 1 | 2006 | 87 | 0.070 |
Why?
|
Nuclear Export Signals | 1 | 2006 | 2 | 0.070 |
Why?
|
Genetic Code | 1 | 2006 | 7 | 0.070 |
Why?
|
Nuclear Localization Signals | 1 | 2006 | 14 | 0.070 |
Why?
|
Internet | 1 | 2008 | 204 | 0.070 |
Why?
|
Trace Elements | 2 | 2016 | 25 | 0.070 |
Why?
|
Active Transport, Cell Nucleus | 1 | 2006 | 54 | 0.070 |
Why?
|
Protein Sorting Signals | 1 | 2005 | 26 | 0.070 |
Why?
|
Testis | 1 | 2007 | 185 | 0.070 |
Why?
|
Homozygote | 1 | 2005 | 75 | 0.070 |
Why?
|
Macromolecular Substances | 1 | 2005 | 86 | 0.070 |
Why?
|
Antigens | 1 | 2005 | 56 | 0.070 |
Why?
|
Mice, Inbred BALB C | 1 | 2007 | 649 | 0.070 |
Why?
|
Heterozygote | 1 | 2005 | 91 | 0.070 |
Why?
|
Models, Genetic | 1 | 2005 | 149 | 0.070 |
Why?
|
Academic Medical Centers | 1 | 2005 | 54 | 0.070 |
Why?
|
Multigene Family | 1 | 2005 | 105 | 0.070 |
Why?
|
Myocardium | 1 | 2007 | 224 | 0.070 |
Why?
|
Protozoan Proteins | 1 | 2006 | 170 | 0.060 |
Why?
|
Evolution, Molecular | 1 | 2006 | 249 | 0.060 |
Why?
|
Hydroxymethylglutaryl-CoA Reductase Inhibitors | 1 | 2005 | 77 | 0.060 |
Why?
|
Lipid Peroxidation | 1 | 2005 | 131 | 0.060 |
Why?
|
Skin | 1 | 2005 | 173 | 0.060 |
Why?
|
Case-Control Studies | 2 | 2019 | 1056 | 0.060 |
Why?
|
Neuroblastoma | 2 | 2017 | 128 | 0.060 |
Why?
|
Fibroblasts | 1 | 2005 | 252 | 0.060 |
Why?
|
Embryonic and Fetal Development | 1 | 2003 | 37 | 0.060 |
Why?
|
Cytoprotection | 1 | 2003 | 32 | 0.060 |
Why?
|
Cytokines | 1 | 2007 | 569 | 0.060 |
Why?
|
Selenoprotein W | 1 | 2003 | 1 | 0.060 |
Why?
|
Research Support as Topic | 2 | 2019 | 75 | 0.060 |
Why?
|
Embryo, Nonmammalian | 1 | 2003 | 57 | 0.060 |
Why?
|
Gene Expression Profiling | 1 | 2007 | 600 | 0.060 |
Why?
|
Risk Assessment | 1 | 2006 | 727 | 0.060 |
Why?
|
Methionine | 1 | 2003 | 28 | 0.060 |
Why?
|
Organ Specificity | 2 | 2000 | 123 | 0.060 |
Why?
|
In Situ Hybridization | 2 | 2000 | 125 | 0.060 |
Why?
|
Computational Biology | 3 | 2014 | 275 | 0.060 |
Why?
|
DNA, Complementary | 4 | 1995 | 175 | 0.050 |
Why?
|
Simian Acquired Immunodeficiency Syndrome | 1 | 2002 | 55 | 0.050 |
Why?
|
Macaca mulatta | 1 | 2002 | 122 | 0.050 |
Why?
|
Phylogeny | 1 | 2005 | 612 | 0.050 |
Why?
|
Mentors | 1 | 2023 | 111 | 0.050 |
Why?
|
Consensus Sequence | 2 | 1999 | 24 | 0.050 |
Why?
|
Databases, Nucleic Acid | 1 | 2002 | 25 | 0.050 |
Why?
|
Program Development | 1 | 2023 | 225 | 0.050 |
Why?
|
Dose-Response Relationship, Drug | 1 | 2005 | 984 | 0.050 |
Why?
|
Blood-Brain Barrier | 1 | 2003 | 153 | 0.050 |
Why?
|
Methanococcus | 1 | 2001 | 1 | 0.050 |
Why?
|
Maryland | 1 | 2021 | 53 | 0.050 |
Why?
|
Creatinine | 1 | 2021 | 101 | 0.050 |
Why?
|
Physical Chromosome Mapping | 1 | 2000 | 10 | 0.050 |
Why?
|
beta-Galactosidase | 1 | 2000 | 34 | 0.050 |
Why?
|
Adenosine Triphosphate | 2 | 2007 | 180 | 0.050 |
Why?
|
Selenious Acid | 1 | 2020 | 3 | 0.050 |
Why?
|
Isoindoles | 1 | 2020 | 17 | 0.050 |
Why?
|
Apoptosis | 1 | 2008 | 1317 | 0.050 |
Why?
|
Pilot Projects | 1 | 2023 | 628 | 0.050 |
Why?
|
Sulfotransferases | 2 | 2010 | 7 | 0.050 |
Why?
|
Chromatography, Affinity | 1 | 2000 | 64 | 0.050 |
Why?
|
Tumor Cells, Cultured | 1 | 2001 | 480 | 0.050 |
Why?
|
Virulence | 1 | 2020 | 221 | 0.050 |
Why?
|
Antibodies | 1 | 2000 | 135 | 0.040 |
Why?
|
Sequence Homology, Nucleic Acid | 2 | 2006 | 84 | 0.040 |
Why?
|
Oligonucleotides | 1 | 1999 | 48 | 0.040 |
Why?
|
Metabolomics | 1 | 2019 | 76 | 0.040 |
Why?
|
Rabbits | 1 | 1999 | 278 | 0.040 |
Why?
|
Proteasome Endopeptidase Complex | 1 | 2019 | 109 | 0.040 |
Why?
|
Intestinal Mucosa | 1 | 2019 | 115 | 0.040 |
Why?
|
Virus Replication | 1 | 2020 | 261 | 0.040 |
Why?
|
MicroRNAs | 2 | 2014 | 386 | 0.040 |
Why?
|
Risk Factors | 1 | 2006 | 3414 | 0.040 |
Why?
|
Prostatic Neoplasms | 1 | 2006 | 794 | 0.040 |
Why?
|
Cultural Diversity | 1 | 2019 | 158 | 0.040 |
Why?
|
Cattle | 1 | 1999 | 472 | 0.040 |
Why?
|
Cell Death | 2 | 2010 | 260 | 0.040 |
Why?
|
Polymorphism, Restriction Fragment Length | 2 | 1995 | 29 | 0.040 |
Why?
|
Structure-Activity Relationship | 3 | 1997 | 376 | 0.040 |
Why?
|
Protein Structure, Secondary | 1 | 1997 | 172 | 0.040 |
Why?
|
Leucine | 1 | 2017 | 28 | 0.040 |
Why?
|
Chromosome Mapping | 2 | 1995 | 159 | 0.040 |
Why?
|
Proline | 1 | 2017 | 37 | 0.040 |
Why?
|
Adult | 3 | 2019 | 11034 | 0.040 |
Why?
|
Homeostasis | 1 | 2018 | 172 | 0.040 |
Why?
|
Terminology as Topic | 1 | 2016 | 32 | 0.040 |
Why?
|
Catalysis | 2 | 1997 | 162 | 0.040 |
Why?
|
Guanosine Triphosphate | 1 | 1995 | 15 | 0.030 |
Why?
|
Metabolic Diseases | 1 | 2016 | 32 | 0.030 |
Why?
|
Models, Molecular | 1 | 1999 | 751 | 0.030 |
Why?
|
Breast Neoplasms | 1 | 2006 | 1426 | 0.030 |
Why?
|
Immunohistochemistry | 2 | 2015 | 859 | 0.030 |
Why?
|
Glucose | 1 | 2017 | 217 | 0.030 |
Why?
|
Thyroxine | 1 | 1995 | 17 | 0.030 |
Why?
|
Tilapia | 1 | 2014 | 7 | 0.030 |
Why?
|
Philippines | 1 | 2014 | 72 | 0.030 |
Why?
|
Blotting, Northern | 3 | 2005 | 139 | 0.030 |
Why?
|
Young Adult | 2 | 2014 | 4012 | 0.030 |
Why?
|
Pacific Islands | 1 | 2014 | 115 | 0.030 |
Why?
|
Psychiatric Status Rating Scales | 1 | 2015 | 243 | 0.030 |
Why?
|
Dementia | 1 | 2015 | 133 | 0.030 |
Why?
|
Mutagenesis | 1 | 1993 | 87 | 0.030 |
Why?
|
Japan | 1 | 2014 | 296 | 0.030 |
Why?
|
Injections, Subcutaneous | 1 | 2013 | 34 | 0.030 |
Why?
|
Microsomes, Liver | 1 | 1993 | 69 | 0.030 |
Why?
|
Rats, Transgenic | 1 | 2013 | 27 | 0.030 |
Why?
|
Kidney Tubules, Proximal | 1 | 1993 | 25 | 0.030 |
Why?
|
Untranslated Regions | 1 | 2012 | 6 | 0.030 |
Why?
|
Ion Transport | 1 | 2012 | 15 | 0.030 |
Why?
|
Diethyl Pyrocarbonate | 1 | 1992 | 1 | 0.030 |
Why?
|
Rose Bengal | 1 | 1992 | 3 | 0.030 |
Why?
|
RNA Splice Sites | 1 | 2012 | 10 | 0.030 |
Why?
|
Health Status Disparities | 1 | 2019 | 583 | 0.030 |
Why?
|
Half-Life | 1 | 1992 | 52 | 0.030 |
Why?
|
Genome-Wide Association Study | 1 | 2014 | 271 | 0.030 |
Why?
|
Cell Line, Transformed | 1 | 1992 | 87 | 0.030 |
Why?
|
Rats, Inbred F344 | 1 | 2013 | 228 | 0.030 |
Why?
|
Escherichia coli | 1 | 1995 | 436 | 0.030 |
Why?
|
Congenital Hypothyroidism | 1 | 1992 | 3 | 0.030 |
Why?
|
Down-Regulation | 1 | 2014 | 420 | 0.030 |
Why?
|
Chromosome Inversion | 1 | 1991 | 4 | 0.030 |
Why?
|
Reticulocytes | 1 | 1991 | 9 | 0.030 |
Why?
|
Aurothioglucose | 1 | 1991 | 1 | 0.030 |
Why?
|
Peptides | 1 | 1994 | 308 | 0.030 |
Why?
|
Xenopus | 1 | 1991 | 44 | 0.030 |
Why?
|
Binding, Competitive | 1 | 1991 | 103 | 0.030 |
Why?
|
Pituitary Gland | 1 | 1991 | 59 | 0.030 |
Why?
|
Chromosome Deletion | 1 | 1991 | 52 | 0.030 |
Why?
|
Intra-Abdominal Fat | 1 | 2011 | 39 | 0.020 |
Why?
|
Organ Size | 1 | 2011 | 148 | 0.020 |
Why?
|
Biotransformation | 1 | 2010 | 65 | 0.020 |
Why?
|
Glucuronosyltransferase | 1 | 2010 | 25 | 0.020 |
Why?
|
Receptors, Interleukin-2 | 1 | 2010 | 29 | 0.020 |
Why?
|
Xenopus laevis | 1 | 1990 | 73 | 0.020 |
Why?
|
Random Allocation | 1 | 2010 | 139 | 0.020 |
Why?
|
Cytochrome P-450 Enzyme System | 1 | 2010 | 82 | 0.020 |
Why?
|
Plant Leaves | 1 | 2010 | 110 | 0.020 |
Why?
|
In Situ Nick-End Labeling | 1 | 2010 | 126 | 0.020 |
Why?
|
Interleukin-2 | 1 | 2010 | 87 | 0.020 |
Why?
|
Energy Intake | 1 | 2010 | 160 | 0.020 |
Why?
|
Oocytes | 1 | 1990 | 143 | 0.020 |
Why?
|
United States | 1 | 2019 | 3894 | 0.020 |
Why?
|
Retrospective Studies | 1 | 2014 | 1961 | 0.020 |
Why?
|
Podocytes | 1 | 2008 | 33 | 0.020 |
Why?
|
Flavonoids | 1 | 2008 | 78 | 0.020 |
Why?
|
Cell Cycle | 1 | 2009 | 309 | 0.020 |
Why?
|
Hyperglycemia | 1 | 2008 | 53 | 0.020 |
Why?
|
Kidney Glomerulus | 1 | 2008 | 80 | 0.020 |
Why?
|
Radiation Tolerance | 1 | 2007 | 12 | 0.020 |
Why?
|
Carrier Proteins | 1 | 2009 | 287 | 0.020 |
Why?
|
Culture Media, Serum-Free | 1 | 2007 | 40 | 0.020 |
Why?
|
Archaeal Proteins | 1 | 2007 | 8 | 0.020 |
Why?
|
Phosphoserine | 1 | 2007 | 18 | 0.020 |
Why?
|
Transferases | 1 | 2007 | 12 | 0.020 |
Why?
|
Dipeptides | 1 | 2007 | 29 | 0.020 |
Why?
|
RNA, Protozoan | 1 | 2006 | 13 | 0.020 |
Why?
|
DNA, Protozoan | 1 | 2006 | 21 | 0.020 |
Why?
|
Cell Differentiation | 1 | 2010 | 562 | 0.020 |
Why?
|
Hydrolysis | 1 | 2007 | 86 | 0.020 |
Why?
|
Chromatography | 1 | 2005 | 15 | 0.020 |
Why?
|
Total Quality Management | 1 | 2005 | 9 | 0.020 |
Why?
|
NIH 3T3 Cells | 1 | 2005 | 60 | 0.020 |
Why?
|
CHO Cells | 1 | 2005 | 107 | 0.020 |
Why?
|
Magnetic Resonance Spectroscopy | 1 | 2007 | 281 | 0.020 |
Why?
|
Serine | 1 | 2005 | 72 | 0.020 |
Why?
|
Immunoprecipitation | 1 | 2005 | 126 | 0.020 |
Why?
|
Cricetinae | 1 | 2005 | 217 | 0.020 |
Why?
|
Transcriptional Activation | 1 | 2005 | 164 | 0.020 |
Why?
|
Green Fluorescent Proteins | 1 | 2005 | 200 | 0.020 |
Why?
|
Microscopy, Fluorescence | 1 | 2005 | 240 | 0.020 |
Why?
|
Cell Proliferation | 1 | 2010 | 1149 | 0.020 |
Why?
|
Rats, Sprague-Dawley | 1 | 2008 | 1534 | 0.020 |
Why?
|
Adolescent | 1 | 2014 | 5035 | 0.010 |
Why?
|
Jurkat Cells | 1 | 2002 | 72 | 0.010 |
Why?
|
Gene Products, tat | 1 | 2002 | 34 | 0.010 |
Why?
|
tat Gene Products, Human Immunodeficiency Virus | 1 | 2002 | 52 | 0.010 |
Why?
|
Simian immunodeficiency virus | 1 | 2002 | 56 | 0.010 |
Why?
|
HIV | 1 | 2002 | 97 | 0.010 |
Why?
|
Socioeconomic Factors | 1 | 2005 | 1003 | 0.010 |
Why?
|
Antineoplastic Agents | 1 | 2008 | 756 | 0.010 |
Why?
|
Middle Aged | 1 | 2015 | 9642 | 0.010 |
Why?
|
Disease Progression | 1 | 2002 | 580 | 0.010 |
Why?
|
Propylthiouracil | 1 | 1997 | 3 | 0.010 |
Why?
|
Dithiothreitol | 1 | 1997 | 18 | 0.010 |
Why?
|
Osmolar Concentration | 1 | 1997 | 55 | 0.010 |
Why?
|
Restriction Mapping | 1 | 1995 | 42 | 0.010 |
Why?
|
Repetitive Sequences, Nucleic Acid | 1 | 1995 | 30 | 0.010 |
Why?
|
Mice, Inbred C3H | 1 | 1995 | 83 | 0.010 |
Why?
|
Cell-Free System | 1 | 1995 | 15 | 0.010 |
Why?
|
Mice, Mutant Strains | 1 | 1995 | 78 | 0.010 |
Why?
|
Introns | 1 | 1995 | 67 | 0.010 |
Why?
|
Microsomes | 1 | 1995 | 52 | 0.010 |
Why?
|
Pancreas | 1 | 1995 | 32 | 0.010 |
Why?
|
Exons | 1 | 1995 | 80 | 0.010 |
Why?
|
Kidney Cortex | 1 | 1993 | 7 | 0.010 |
Why?
|
Kidney Medulla | 1 | 1993 | 6 | 0.010 |
Why?
|
RNA Probes | 1 | 1993 | 10 | 0.010 |
Why?
|
Genomic Library | 1 | 1992 | 7 | 0.010 |
Why?
|
Affinity Labels | 1 | 1992 | 7 | 0.010 |
Why?
|